Acadia wins EU approval for DAYBU as first treatment for Rett syndrome

Gilead expands Trodelvy role in first-line metastatic triple-negative breast cancer in Europe

GSK's Jemperli wins FDA priority review for advanced rectal cancer

European Commission grants orphan designation for Lundbeck's asedebart

Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial

Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment

Maverix Medical's Narwhal Cryo System receives FDA 510(k) clearance

Implantica's RefluxStop receives US FDA approval

Lupin's VISUfarma signs European licensing deal for presbyopia therapy YUVEZZI

Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure

Harbour BioMed IND for HBM7004 approved by China's NMPA

Hansa Biopharma reports first Australian transplant using Idefirix

Lupin's Pitolisant Tablets receives US FDA approval

Acurx receives FDA conditional acceptance for ibezapolstat brand name

Lttl announces new telehealth site